Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Alice Onady

Psychiatry Middletown, OH Medical Doctor

NPI 1518997741 CMS profile 114320

4464 S Dixie Hwy, Middletown, OH 45005

Open in the dashboard

General payments

$8,874

796 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Alice Onady of Middletown, OH is reported in the CMS Open Payments database as having received $8,874 across 796 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $248 12
2022 General $1,650 137
2021 General $2,564 204
2020 General $2,082 180
2019 General $2,329 263

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alice Onady
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Alice Onady were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Alice Onady Psychiatry median Middle half National median
2019 $2,329 $184 $59–$605 $163
2020 $2,082 $119 $36–$372 $114
2021 $2,564 $143 $43–$576 $132
2022 $1,650 $153 $50–$590 $149
2023 $248 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Janssen Pharmaceuticals, Inc $1,439 80 payments
  2. Alkermes, Inc. $1,146 119 payments
  3. Sunovion Pharmaceuticals Inc. $1,090 99 payments
  4. Otsuka America Pharmaceutical, Inc. $1,084 102 payments
  5. Lundbeck LLC $834 107 payments
  6. Teva Pharmaceuticals USA, Inc. $642 44 payments
  7. Vanda Pharmaceuticals Inc. $528 23 payments
  8. AbbVie, Inc. $525 65 payments
  9. Allergan Inc. $432 66 payments
  10. Axsome Therapeutics, Inc. $339 17 payments
  11. Other $813 74 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $8,611 785 payments
  2. Education $263 11 payments
Products named General payments · program years 2019–2023
  1. INVEGA SUSTENNA $1,276 71 payments
  2. INVEGA TRINZA $1,257 70 payments
  3. SPRAVATO $1,252 71 payments
  4. LATUDA $1,090 99 payments
  5. ARISTADA INITIO $863 104 payments
  6. ARISTADA Cns $863 104 payments
  7. ARISTADA Cns $863 104 payments
  8. REXULTI $734 79 payments
  9. ARISTADA Cns $590 68 payments
  10. ARISTADA Cns $590 68 payments
  11. Other $6,267 556 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

796 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record